Ovarian Cancer Clinical Trials

A listing of Ovarian Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study evaluating LDE225 for the treatment of Recurrent Ovarian Cancer or Platinum Resistant

Huntsville Alabama 35805

A Phase 3 clinical study for patients with Ovarian Cancer or Ovarian Neoplasm, Fallopian Tube, or Primary Peritoneal Cancer

Mobile Alabama 36604

A Phase 3 clinical study for patients with Ovarian Cancer or Ovarian Neoplasm, Fallopian Tube, or Primary Peritoneal Cancer

Mobile Alabama 36604

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

Alaska

Anchorage Alaska 99508

A Phase 3 clinical study for patients with Ovarian Cancer or Ovarian Neoplasm, Fallopian Tube, or Primary Peritoneal Cancer

Anchorage Alaska 99508

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Arizona

Arizona Oncology Associates
Phoenix Arizona

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Arizona Oncology Associates
Tucson Arizona

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

View More ▼

UPDATED

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Goodyear Arizona 85338

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Peoria Arizona

Patients are needed to participate in a clinical research study of Lurbinectedin (PM01183), Pegylated liposomal doxorubicin (PLD) and Topotecan to evaluate Ovarian Cancer

Phoenix Arizona

A clinical trial to evaluate treatments using Niraparib for patients with Ovarian Cancer

Phoenix Arizona 85016

A Phase 3 clinical study for patients with Ovarian Cancer or Ovarian Neoplasm, Fallopian Tube, or Primary Peritoneal Cancer

Scottsdale Arizona 85258

A clinical trial to evaluate treatments using EC1456 and EC20 for patients with advanced solid tumors

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating Ferumoxytol followed by MM-398

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating PLX3397 and Pembrolizumab to treat Advance Melanoma and Other Solid Tumors

Tucson Arizona

A clinical trial to evaluate treatments using Niraparib for patients with Ovarian Cancer

Tucson Arizona 85711

A Phase 3 clinical study for patients with Ovarian Cancer or Ovarian Neoplasm, Fallopian Tube, or Primary Peritoneal Cancer

Tucson Arizona 85715

Patients are needed to participate in a clinical research study evaluating Mifepristone and Eribulin in combination for the treatment of Breast Cancer

Tucson Arizona 85704

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Tucson Arizona 85719

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

California

Sutter West Bay
San Francisco California

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

View More ▼

Concord California 94520

A Phase 3 clinical study for patients with Ovarian Cancer or Ovarian Neoplasm, Fallopian Tube, or Primary Peritoneal Cancer

Duarte California 91010

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer

Duarte California 91010

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Duarte California

A clinical trial to evaluate treatments using Niraparib for patients with Ovarian Cancer

Fullerton California 92835

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Fullerton California 92835

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Greenbrae California 94904

Patients are needed to participate in a clinical research study evaluating PLX3397 and Pembrolizumab to treat Advance Melanoma and Other Solid Tumors

Greenbrae California

Patients are needed to participate in a clinical research study of Lurbinectedin (PM01183), Pegylated liposomal doxorubicin (PLD) and Topotecan to evaluate Ovarian Cancer

Irvine California 92618

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

La Jolla California 92037

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

La Jolla California 92093

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

La Jolla California

Patients are needed to participate in a clinical research study of Lurbinectedin (PM01183), Pegylated liposomal doxorubicin (PLD) and Topotecan to evaluate Ovarian Cancer

Los Angeles California 90048

A clinical trial seeking patients for a research study of compound 31543 Calcitriol

Los Angeles California 90024

A clinical trial to evaluate treatments using AM0010 in Patients With Advanced Solid Tumors

Los Angeles California

A clinical trial to evaluate treatments using Niraparib for patients with Ovarian Cancer

Los Angeles California 90027

A Phase 3 clinical study for patients with Ovarian Cancer or Ovarian Neoplasm, Fallopian Tube, or Primary Peritoneal Cancer

Los Angeles California 90095

Patients are needed to participate in a clinical research study evaluating MGA271 plus Ipilimumab for the treatment of Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer

Los Angeles California 90095

Patients are needed to participate in a clinical research study evaluating PLX3397 and Pembrolizumab to treat Advance Melanoma and Other Solid Tumors

Los Angeles California

Patients are needed to participate in a clinical research study of AZD5363

Los Angeles California 90045

Patients are needed to participate in a clinical research study of CM-24

Los Angeles California

Patients are needed to participate in a clinical research study of Lurbinectedin (PM01183), Pegylated liposomal doxorubicin (PLD) and Topotecan to evaluate Ovarian Cancer

Los Angeles California 90404

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Mountain View California 94040

A Phase 3 clinical study for patients with Ovarian Cancer or Ovarian Neoplasm, Fallopian Tube, or Primary Peritoneal Cancer

Orange California 92868

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Palo Alto California

Patients are needed to participate in a clinical research study of Lurbinectedin (PM01183), Pegylated liposomal doxorubicin (PLD) and Topotecan to evaluate Ovarian Cancer

Palo Alto California 94304

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer